Cohance Lifesciences Ltd banner

Cohance Lifesciences Ltd
NSE:COHANCE

Watchlist Manager
Cohance Lifesciences Ltd Logo
Cohance Lifesciences Ltd
NSE:COHANCE
Watchlist
Price: 295.6 INR 4.62%
Market Cap: ₹113.1B

Wall Street
Price Targets

COHANCE Price Targets Summary
Cohance Lifesciences Ltd

Wall Street analysts forecast COHANCE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COHANCE is 524.54 INR with a low forecast of 343.4 INR and a high forecast of 1 207.5 INR.

Lowest
Price Target
343.4 INR
16% Upside
Average
Price Target
524.54 INR
77% Upside
Highest
Price Target
1 207.5 INR
308% Upside
Cohance Lifesciences Ltd Competitors:
Price Targets
PLRX
Pliant Therapeutics Inc
138% Upside
SPH
Suburban Propane Partners LP
-15% Downside

Revenue
Forecast

8% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
38% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 5 years the compound annual growth rate for Cohance Lifesciences Ltd's revenue is 8%. The projected CAGR for the next 3 years is 38%.

Operating Income
Forecast

-2% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
-2% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 5 years the compound annual growth rate for Cohance Lifesciences Ltd's operating income is -2%. The projected CAGR for the next 3 years is 24%.

Net Income
Forecast

-3% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-37%
Average Miss
-3% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-37%
Average Miss

For the last 5 years the compound annual growth rate for Cohance Lifesciences Ltd's net income is -3%. The projected CAGR for the next 3 years is 21%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COHANCE's stock price target?
Price Target
524.54 INR

According to Wall Street analysts, the average 1-year price target for COHANCE is 524.54 INR with a low forecast of 343.4 INR and a high forecast of 1 207.5 INR.

What is Cohance Lifesciences Ltd's Revenue forecast?
Projected CAGR
38%

For the last 5 years the compound annual growth rate for Cohance Lifesciences Ltd's revenue is 8%. The projected CAGR for the next 3 years is 38%.

What is Cohance Lifesciences Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 5 years the compound annual growth rate for Cohance Lifesciences Ltd's operating income is -2%. The projected CAGR for the next 3 years is 24%.

What is Cohance Lifesciences Ltd's Net Income forecast?
Projected CAGR
21%

For the last 5 years the compound annual growth rate for Cohance Lifesciences Ltd's net income is -3%. The projected CAGR for the next 3 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett